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ble to oxacillin and other antibiotics tested. The patient’s symptoms
resolved and the follow-up period was two months.
Both adolescents had no history of diabetes, smoking, sexual activ-
ity, or corticosteroid/contraceptive use. The age of menarche in both
girls was 11 years. Predisposing factors for mastitis and breast ab-
scess include skin lesions, mammary duct ectasia, trauma related to
sexual foreplay, nipple piercing, and shaving or plucking periareolar
hair [3,4]. None of these factors was identified in the cases described.
Breast malignancy, tuberculosis, and protozoal and fungal infections
are differential diagnoses for mastitis [3].
In both cases, management with oral antibiotic therapy and
ultrasound-guided needle aspiration was successful. Surgical drain-
age should be reserved for unresolved cases following aspiration.
This is especially valid for adolescents as surgery may affect the breast
bud, resulting in impaired breast development [3].
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In support of the reproductive rights and promotion of reproduc-
tive justice for HIV-affected couples desiring children, implementa-
tion studies are needed to guide the integration of evidence-based
interventions in Sub-Saharan Africa. HIV-affected couples desiring
children in this region need equitable access to assisted reproductive
services (e.g. vaginal insemination, sperm washing with intrauterine
insemination, and in vitro fertilization) as components of HIV preven-
tion interventions. Inadequate action to address the reproductive pri-
orities of HIV-affected couples may thwart HIV prevention
interventions because couples knowingly risk sexual and perinatal
HIV to fulfill their reproductive goals [1]. The present article calls for
a shift in the global perspective to address the reproductive desires
of individuals and couples affected by HIV.
In Sub-Saharan Africa, HIV-affected couples desiring children are
counseled to limit unprotected intercourse to the peak fertile period
to limit HIV exposure. Pre-exposure prophylaxis is recommended in
high-risk partnerships [2], but is not readily available in low-resource
settings. In middle- and high-resource countries, HIV-affected cou-
ples desiring children have greater options for assisted reproductive
services [3,4] and greater access to pre-exposure prophylaxis [5],
which may allow couples to conceive while limiting the risk of HIV
transmission to their uninfected partner and child (Box 1).
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Box 1
Studies demonstrating the efficacy of safer conception methods
for HIV-affected couples.
• Treatment of the HIV-infected partner as prevention [6].
• Pre-exposure prophylaxis [5,7].
• Voluntary male medical circumcision [8–10].
• Sperm washing with intrauterine insemination [11,12].
• In vitro fertilization, intracytoplasmic sperm injection
[13,14,15].
We should seek to achieve equitable options and access to assisted
reproductive services for HIV-serodiscordant couples desiring chil-
dren in Sub-Saharan Africa, particularly in communities with a high
prevalence of HIV and cultures where social identity and value are in-
extricably linked to reproduction.
Traditionally, “family planning” has referred mainly to contracep-
tion and safe abortion. However, it should also embrace a reproduc-
tive justice framework that addresses each individual’s reproductive
need across their life cycle [16]. For HIV-affected couples, this in-
cludes access to safer conception education, counseling, and clinical
services as components of HIV prevention interventions. Access and
provision of safer conception services is an innovative approach to
HIV prevention that challenges the status quo and addresses the
needs of a critical at-risk population. Implementation studies evaluat-
ing safer conception services in Sub-Saharan Africa will highlight the
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barriers and facilitators that may affect the integration and scale-up of
evidence-based safer conception programs from high-resource coun-
tries. Furthermore, these implementation studies will identify the
adaptable program components to ensure cost-effective and sustain-
able services in low-resource settings. From a reproductive justice
perspective, HIV prevention programs should include accessible
safer conception services for HIV-affected couples. Financial support
needed to achieve this goal may require commitment from founda-
tions and national and global organizations to strengthen HIV preven-
tion efforts and assure the reproductive rights of HIV-affected
couples.
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Obstetric hemorrhage, the leading cause of maternal mortality, ac-
counts for up to 44% of maternal deaths in regions of West and East
Sub-Saharan Africa; 26% of these deaths can be attributed to the paucity
of donated blood available for emergency transfusions [1]. This situation
complicates the efforts of clinicians to treat ruptured ectopic pregnancy,
which is the largest contributor tomortality in the first trimester. Auto-
transfusion is a life-saving intraoperative blood salvage procedure that
is routinely performed using automated blood salvage devices in
high-income countries [2]. Such devices are inappropriate for
low-income countries owing to their cost and complexity (i.e. difficult
to maintain), among other factors [3]. Furthermore, effective manual
blood salvage solutions including the soup ladle method [4] and the
Tanguieta funnel [3] developed for use in low-income countries can
be labor intensive and require numerous disposables.
Design ethnography studies including clinical observations and in-
terviews were conducted primarily at Komofo Anokye Teaching
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